$RVP News

Retractable Stock Slips Post Q1 Earnings, Sales Decline Y/Y

Retractable Technologies, Inc. Results for the Period Ended March 31, 2026

Retractable Technologies Q1 EPS $(0.14) Up From $(0.35) YoY, Sales $7.177M Down From $8.295M YoY

Retractable Technologies, Inc. Announces Workforce Reduction

Retractable Technologies Reduces Workforce By ~16%; Reduction Expected To Save $2.2M In Annual Wages And Benefits; Estimated One-time Separation Payments Of ~$122K To Affected Workers

RVP Stock Plunges Post Q4 Earnings Despite Revenue Growth

Retractable Technologies, Inc. Reports Results for 2025

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Retractable Technologies Q4 EPS $(0.08) Down From $0.13 YoY, Sales $9.440M Up From $9.074M YoY

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

RVP Stock Rises Post Q3 Earnings Despite Tariff and Cost Pressures

Retractable Technologies, Inc. Results for the Periods Ended September 30, 2025

Retractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle

Retractable Technologies Says Tariffs Are Expected To Continue To Materially Impact Our Costs In Future Periods; Working To Lessen Financial Impact Of Tariffs & Have Shifted To A Larger Proportion Production To Us Facility

Retractable Technologies Q3 EPS $0.01 Up From $(0.07) YoY, Sales $10.086M Down From $10.347M YoY

Retractable Technologies' EasyPoint Blood Collection Tube Holder Earns Vizient Innovative Technology Designation

Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders

Retractable Technologies Stock Gains Following Q2 Earnings Growth

Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025

Retractable Technologies: Q2 Earnings Snapshot